Krishna Chinthalapudi

[Krishna Chinthalapudi @CellAdhesion]

Structural basis of human Nav1.5 gating mechanisms | PNAS https://t.co/sZpdzH7k00

[World Health Organization (WHO) @WHO]

What the industry is hiding about nicotine pouches:

☠️ Addictive: designed to hook you fast
🧪 Toxic: unregulated levels of nicotine
❤️ Increased risk of cardiovascular disease
🧠 Damages brain development

No smoke. No smell. No warning.
Around 160 countries have NO specific regulations for nicotine pouches. The industry is exploiting every gap.
It's time to expose them. #TobaccoExposed

[Krishna Chinthalapudi @CellAdhesion]

@ktr_nakanishi Congratulations Kotaro!

[Alushin_Lab @Alushin_Lab]

Very pleased that after a rigorous (and lengthy) review process, our paper visualizing how myosin generated forces modulate actin filament structure for mechanosensitive recogntion by α-catenin has appeared in @Nature

https://t.co/gzEziWL8aB

[Krishna Chinthalapudi @CellAdhesion]

@Alushin_Lab @Nature Congratulations! Glad this important work is finally out.

[The Ohio State Univ. Physiology and Cell Biology @OhioStatePCB]

A new study from @Heissler_Lab titled MYH9 mutations differentially stabilize non-muscle myosin II filaments and induce distinct cellular aggregation phenotypes published in Cellular and Molecular Life Sciences https://t.co/L1OOuLzXwI @OhioStateDHLRI @OhioStateMed

[The Ohio State Univ. Physiology and Cell Biology @OhioStatePCB]

Exciting study from Deschenes and Chinthalapudi @CellAdhesion labs. Structural and functional mechanisms underlying activation gate dynamics and IFM motif accessibility in human Nav1.5. https://t.co/GI4a7Jr6di @NatureComms @OSUWexMed @OhioStateDHLRI @OhioStateMed

[NIH Funding @NIHFunding]

Basic Experimental Studies in Humans (BESH) Will No Longer Be Considered Clinical Trials by the NIH https://t.co/23omlCCZn9

[The Ohio State Univ. Physiology and Cell Biology @OhioStatePCB]

A new collaborative paper from @Heissler_Lab and @CellAdhesion lab. Actin arginylation alters myosin engagement and F-actin patterning despite structural conservation https://t.co/FqRRQntJGa @OhioStateDHLRI @OSUWexMed

[Krishna Chinthalapudi @CellAdhesion]

@GarikipatiSrik2 @OhioStatePCB @osuresearch @OhioStateDHLRI @OhioStateERIK @OhioStateMed Thank you

[Jason Shepherd @JasonSynaptic]

Vought has ordered a halt on all extramural NIH funding for the rest of the FY. No words. You cannot let this stand @SenateDems @SenateGOP @NIHDirector_Jay @hubermanlab

https://t.co/tJSaWl7Ddk Trump Administration Puts New Chokehold on Billions in Health-Research

[Chris Toseland @ChrisToseland]

We are walking the Ullswater Way with @OscarsCharity in May.

Learn more and donate here: https://t.co/5IBDxX9cd2

#braintumours #childhoodcancer #cancer

[Krishna Chinthalapudi @CellAdhesion]

@PDBeurope @BiophysicalSoc Congratulations Hsiang-Ling! We are very proud of you. Thanks wwPDB for the award.

[Prof. Nikolai Slavov @slavov_n]

NIH has stopped considering new grant applications, delaying decisions about how to spend millions of dollars.

The freeze occurred because the Trump administration has blocked the NIH…

https://t.co/YX2AxyfdDE

[Sri Kosuri @srikosuri]

It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS, indeterminate dendritic cell histiocytosis or other (non-LCH) histiocytic sarcomas cases.

I'm trying to understand non-surgical chemo and targeted therapy options, new pathology markers to better diagnose subtypes/treatments, and any data on progression in pediatric patients. Please feel free to share – I’m trying to cast a wide net due to the rarity of this condition and how little is known.

People can contact me directly at my first name (as written in my profile) at https://t.co/ubo0zQRMn0.

[Krishna Chinthalapudi @CellAdhesion]

@ArgallPhd Congratulations guys! We are so happy for you.

[Krishna Chinthalapudi @CellAdhesion]

I’m looking for a motivated postdoc to join my lab with a structural biology background. Reach out to me if you are interested in the structure-function studies of actin cytoskeleton and membrane repair processes.

[Nature Communications @NatureComms]

@CellAdhesion @Heissler_Lab report the structure of dysferlin, offering insights into its molecular mechanisms and how mutations impair its function #dysferlin #membrane_repair

https://t.co/M9y6CFu0X7

[Krishna Chinthalapudi @CellAdhesion]

Our latest research on dysferlin has just been published. @Heissler_Lab.
https://t.co/Jd7YWzgPmM #membrane_repair #dysferlin #dysferlinopathy

[Krishna Chinthalapudi @CellAdhesion]

Our work on membrane repair protein dysferlin is published in Nature Communications. Very proud of the team. https://t.co/YMhLM8jwFY